This inventor holds 1 USPTO granted patent. Top assignees: Duke University, Mayo Foundation for Medical Education and Research. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024
Title: Innovations in Cancer Treatment by Luis Sanchez-Perez
Introduction
Luis Sanchez-Perez is an accomplished inventor based in Apex, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on utilizing oncolytic viruses and modified CAR T cells to enhance cancer treatment efficacy.
Latest Patents
Luis Sanchez-Perez holds a patent for "Materials and methods for treatment with oncolytic viruses and modified CAR T cells." This patent relates to methods and materials involved in treating cancer. It provides innovative approaches for using one or more oncolytic viruses in combination with adoptive cell therapy, such as chimeric antigen receptor T cell therapy. The goal is to alter T cell functions and enhance T cell expansion to effectively treat cancer in mammals, including humans. He has 1 patent to his name.
Career Highlights
Throughout his career, Luis has worked with prestigious institutions, including the Mayo Foundation for Medical Education and Research and Duke University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Luis has collaborated with notable colleagues, including Laura Evgin and Richard G. Vile. These partnerships have further enriched his research and development efforts in cancer treatment.
Conclusion
Luis Sanchez-Perez is a pioneering inventor whose work in cancer treatment through innovative methods and materials has the potential to significantly impact patient care. His dedication to advancing medical science is evident in his research and collaborations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile